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Cellular assays for suspension cells provide investigators
the opportunity to interrogate the biology of cellular
function of immune cells or immunotherapeutic drugs.
Despite significant technical advances made during the
last few years, working with suspension cells, such as pri-
mary blood cells, PBMCs (peripheral blood mononuclear
cells), leukemia, myeloma, or lymphoma cells, cellular
assays still suffer from limitations. For example, even for
HEK 293 cells, a commonly used semi-adherent cell line,
significant cell loss can occur during assay process. This
loss can be further exacerbated when multi-step staining
procedures are required.
We applied DropArray plates, which employ surface ten-
sion to retain cells on the plate surface, for our suspension
cellular assays. For a variety of suspension cells, including
PBMCs, AML cells, or B cells, efficient retention (50% to
80%) is achieved during multiple washes. Reproducibility
and quality of the experimental results are improved with
DropArray plates. Furthermore, the specific cytotoxic
action of bispecific antibody on tumor cells can be also
observed in real time.
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